Correlation Between Nalwa Sons and Rossari Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Nalwa Sons and Rossari Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nalwa Sons and Rossari Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nalwa Sons Investments and Rossari Biotech Limited, you can compare the effects of market volatilities on Nalwa Sons and Rossari Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nalwa Sons with a short position of Rossari Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nalwa Sons and Rossari Biotech.

Diversification Opportunities for Nalwa Sons and Rossari Biotech

-0.76
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Nalwa and Rossari is -0.76. Overlapping area represents the amount of risk that can be diversified away by holding Nalwa Sons Investments and Rossari Biotech Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rossari Biotech and Nalwa Sons is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nalwa Sons Investments are associated (or correlated) with Rossari Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rossari Biotech has no effect on the direction of Nalwa Sons i.e., Nalwa Sons and Rossari Biotech go up and down completely randomly.

Pair Corralation between Nalwa Sons and Rossari Biotech

Assuming the 90 days trading horizon Nalwa Sons Investments is expected to generate 2.52 times more return on investment than Rossari Biotech. However, Nalwa Sons is 2.52 times more volatile than Rossari Biotech Limited. It trades about 0.23 of its potential returns per unit of risk. Rossari Biotech Limited is currently generating about 0.08 per unit of risk. If you would invest  642,120  in Nalwa Sons Investments on September 4, 2024 and sell it today you would earn a total of  160,150  from holding Nalwa Sons Investments or generate 24.94% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Nalwa Sons Investments  vs.  Rossari Biotech Limited

 Performance 
       Timeline  
Nalwa Sons Investments 

Risk-Adjusted Performance

16 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Nalwa Sons Investments are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Nalwa Sons unveiled solid returns over the last few months and may actually be approaching a breakup point.
Rossari Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Rossari Biotech Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest uncertain performance, the Stock's basic indicators remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the firm traders.

Nalwa Sons and Rossari Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Nalwa Sons and Rossari Biotech

The main advantage of trading using opposite Nalwa Sons and Rossari Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nalwa Sons position performs unexpectedly, Rossari Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rossari Biotech will offset losses from the drop in Rossari Biotech's long position.
The idea behind Nalwa Sons Investments and Rossari Biotech Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Other Complementary Tools

Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios